Assessment of Geriatric Evaluations Impact on New AML Guidance

Participation Deadline: 12/01/2026
Apply Now

Description

The goal of the study is to measure physiologic age (there is no current formal definition but is meant to imply that patients should be evaluated holistically rather than on age alone) at baseline in newly diagnosed AML patients over 50 years receiving either intensive or non-intensive treatment. This information will be used to evaluate toxicity, early mortality, remission rates and long term survival.